Business · 27/01/2010Updated: 10/17/2026 · 1 min read
FDA Releases Draft Guidance on Abuse Potential of New Drugs
Summary
The Food and Drug Administration (FDA) has made available a draft guidance document to help pharmaceutical companies assess the potential for abuse of new medications, which may require scheduling under the Controlled Substances Act.
Original source language: Federal Register — Health and Human ServicesOpen original release →